Scott L. Tarriff serves as Executive at PAR PHARMACEUTICAL COMPANIES, INC., where they oversee executive responsibilities. Since joining the company, Scott L. Tarriff has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 9, 2006 involved receiving (via award) 26,399 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 9, 2006 | PRX | $0 | Award | 26,399 | $N/A | Discretionary |
Scott L. Tarriff currently holds 47,461 shares of PAR PHARMACEUTICAL COMPANIES, INC. (PRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott L. Tarriff has been a net neutral trader of PRX stock. They have purchased $0 and sold $0 worth of shares.
Scott L. Tarriff's most recent insider trade was on Jan 9, 2006, when they sold 26,399 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted